Malta Consensus Statements on Paranasal Sinus Disorders in SCUBA Diving: Results of a Delphi Study Authors: B. Y. Roukema, H. F. van Waegeningh, R. J. P. Briët, H. G. Bremer, S. M. Reinartz Published: 2026 ABSTRACT ABSTRACTObjectivesTo establish expert consensus on the diagnostic approach, treatment strategies, and fitness‐to‐dive assessment for divers with paranasal sinus disease, addressing the current lack of specific guidelines for this frequent diving‐related disorder.MethodsA rapid, conference‐based modified Delphi process was conducted with a panel of 14 Dutch otorhinolaryngologists, including four certified diving medicine specialists. Consensus was defined as more than 80% agreement.ResultsThe panel achieved consensus on recommendations across four domains. For diagnosis, a comprehensive ENT evaluation including nasal endoscopy is recommended; low‐dose CT‐imaging is advised for persistent or recurrent cases to identify anatomical obstructions. Primary management is conservative, adhering to EPOS guidelines. Functional endoscopic sinus surgery (FESS) is reserved for cases refractory to medical therapy, particularly those with anatomical obstruction. Postoperatively, it is advised to refrain from diving for a minimum of 8 weeks. Return to diving requires confirmed mucosal healing via endoscopy and a test dive under controlled conditions.ConclusionsThis Delphi‐based consensus provides practical, evidence‐informed guidance for clinicians, bridging the gap in formal guidelines and promoting uniform evaluation and treatment strategies within diving medicine. Introduction Barosinusitis, or sinus barotrauma, is defined as inflammation or injury of the paranasal sinus mucosa caused by a pressure differential between the sinus cavity and the ambient environment [1]. This typically results from rapid pressure changes which can lead to failure to equalize during diving or in aviation. Clinically, it manifests as acute, severe facial pain, often accompanied by epistaxis. Although rare, severe complications such as meningitis, pneumocephalus, or visual loss have been reported [1]. Epidemiological data indicate that up to 34% of Self‐Contained Underwater Breathing Apparatus (SCUBA) divers experience at least one episode of sinus barotrauma during their diving career [2]. In the Netherlands, a national survey among diving instructors identified ENT problems as one of the most common medical conditions [3]. Globally, studies show that approximately 80% of adults and 85% of juvenile divers report ear, nose, or throat complaints related to diving [4, 5, 6, 7], with rhinologic and oral‐maxillofacial complications accounting for approximately 35% of head and neck pathology related to diving [8], and more than 10% of experienced divers reporting a documented history of paranasal sinus barotrauma during their diving career [6]. Furthermore, ENT comorbidity has been identified as a strong predictor of diving accidents [9]. Despite this high prevalence, evidence‐based guidelines for the management of divers with sinonasal pathology are absent. Treatment is often extrapolated from general rhinosinusitis guidelines, leading to significant practice variation. To address this, the ENT‐Diving Medicine Working Group initiated a structured consensus project to harmonize the evaluation, management, and determination of fitness to dive for this specific patient population. Methods Study Design We employed a modified Delphi approach to achieve expert consensus. In contrast to a classical Delphi methodology, this process was designed as a pragmatic, conference‐based approach combining iterative survey rounds with structured group discussion. Participants rated agreement on proposed statements and provided qualitative feedback, which was used to refine subsequent iterations. Final consensus was reached during an in‐person meeting. Formal quantitative Delphi metrics (e.g., median ratings, interquartile ranges) were not systematically collected, and statements not reaching consensus were not reported separately. Consensus was defined a priori as ≥ 80% agreement, but the process emphasized iterative refinement and group convergence rather than strictly quantitative analysis. Panel Composition The expert panel consisted of 14 Dutch otorhinolaryngologists, four of whom are also certified medical examiners of divers according to ECHM/EDTC standards. Panel members work in different hospitals distributed across the Netherlands and were recruited on the basis of active clinical practice in otorhinolaryngology and familiarity with diving‐related ENT presentations. All 14 panel members are listed by name and affiliation in the acknowledgments. Ethical Considerations The study protocol was reviewed by the Institutional Review Board of Tergooi Medical Center and deemed exempt from formal review as the study involved expert consensus without direct patient intervention or use of patient data. Statement Development The working group, consisting of the four authors, drafted an initial list of 21 statements over several months prior to the Delphi rounds. Statement development was based on a targeted review of available literature on barosinusitis, chronic rhinosinusitis management, diving medicine, and fitness‐to‐dive assessment, combined with expert clinical experience. Topics included diagnostic approaches, therapeutic strategies, surgical indications, and postoperative fitness‐to‐dive assessment. Delphi Procedure The process consisted of three rounds conducted between June 18 and June 22, 2025: Round 1 (June 18, 80% response rate) and Round 2 (June 21, 90% response rate) were conducted electronically. During each round, participants provided agreement/nonagreement voting combined with qualitative written feedback. Feedback was reviewed by the working group and used to revise the statements, clarify definitions, and address areas of disagreement prior to redistribution in the subsequent round. Round 3 (June 22) consisted of a final in‐person consensus meeting held in Malta during a scheduled diving medicine educational meeting attended by all panel participants. Remaining disagreements were discussed until consensus was reached. Malta was selected as the venue because it is one of Europe's principal recreational diving destinations, offering direct access to the underwater environment central to this topic. A substantial proportion of the panel participated in supervised dives, and the panel also visited the Hyperbaric Unit on Gozo. This visit was considered relevant to the clinical recommendations being developed. Results All final statements achieved the predefined consensus threshold of ≥ 80% agreement following iterative refinement and structured group discussion. Because of the pragmatic conference‐based design, detailed quantitative voting matrices and interquartile analyses were not systematically collected. The consensus recommendations are categorized into four domains: diagnostic evaluation, therapeutic strategy, surgical management, and postoperative fitness to dive. The complete list of consensus statements is provided in Table 1. TABLE 1Malta consensus statements on paranasal sinus disorders in SCUBA diving.DomainConsensus statement1. Diagnostic evaluationDivers presenting with nasal or sinonasal complaints should undergo a comprehensive ENT evaluation, including nasal endoscopy. Depending on clinical findings and history, allergy testing may be indicated.Given the potential risks of barosinusitis, a low threshold for CT imaging of the sinuses is recommended in cases of persistent or recurrent symptoms to identify predisposing factors such as sinusitis or anatomical obstruction.2. Therapeutic strategyInitial management should be conservative and medical. If optimal conservative therapy fails, a negative recommendation for diving fitness may be issued. If the diver is motivated and the pathology is suitable, surgical intervention may be considered.Medical treatment of acute (ABS), recurrent acute (RABS), and chronic barosinusitis (CBS) should follow established rhinosinusitis guidelines (e.g., EPOS). In selected cases, the use of biologics may be considered.For acute barosinusitis occurring during or shortly after a dive, a short course of vasoconstrictive nasal spray and/or systemic corticosteroids is recommended to relieve symptoms and prevent complications.3. Surgical managementSurgical intervention (FESS or alternative sinus procedures) should be considered in divers who fail optimal medical therapy. Because of repeated exposure to pressure changes, creating a sufficiently wide and stable sinus opening is essential to prevent restenosis.Surgical success rates regarding fitness to dive are higher in divers whose barosinusitis is primarily caused by anatomical obstruction than in those with predominant mucosal inflammation.4. Postoperative fitness to diveAfter sinus surgery (FESS), diving is considered contraindicated for at least 8 weeks.Once symptoms have resolved and complete mucosal healing is confirmed (no earlier than 8 weeks postoperatively), a supervised test dive under controlled conditions, preceded by nasal endoscopic evaluation, is recommended to confirm the safe return to diving. Malta consensus statements on paranasal sinus disorders in SCUBA diving. Discussion Diagnostic Evaluation The panel emphasized the necessity of nasal endoscopy, as incidental mucosal thickening is common even in asymptomatic divers [10]. However, in divers with a history of barotrauma, identifying correctable pathology is paramount. The recommendation for allergy testing is supported by evidence showing a high prevalence of allergic rhinitis in divers with barotrauma [11, 12]. Allergic mucosal edema can compromise ostial patency, increasing recurrence risk [13]. Regarding imaging, the consensus advises a low threshold for CT‐scanning in recurrent cases. This aligns with findings that recurrent episodes often stem from anatomical obstructions (e.g., in the frontal recess) or chronic inflammation not visible on rhinoscopy [1, 14]. A systematic review noted that the frontal sinus is most frequently involved (59%), likely due to the complexity of the frontal recess [14]. Therapeutic Strategy Conservative management remains the first line of treatment. Most divers recover with appropriate medication and a temporary diving pause; Skevas et al. reported similar long‐term diving fitness rates (> 90%) in medically versus surgically treated divers [13]. For acute cases, decongestants and corticosteroids facilitate rapid mucosal recovery. For chronic conditions, the panel recommends adherence to the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) guidelines [15], which advocate for long‐term nasal corticosteroids and saline irrigations. The mention of biologics represents a forward‐looking consideration for selected patients with severe eosinophilic chronic rhinosinusitis with nasal polyps, extrapolated from general CRS‐management principles [15, 16] rather than diving‐specific evidence. At present, evidence regarding biologics in diving populations remains lacking. Surgical Management When medical therapy fails, functional endoscopic sinus surgery (FESS) is the preferred intervention. Studies report high success rates for symptom resolution in divers, ranging from 85% to 91% [13, 14]. However, the consensus highlights that outcomes are superior when the underlying cause is anatomical (e.g., septal deviation, concha bullosa) rather than diffuse mucosal inflammation [11]. This distinction is critical; divers with diffuse inflammatory disease often require continued medical maintenance postsurgery to remain fit to dive, consistent with findings in nondiving CRS populations [16]. Postoperative Fitness to Dive Determining when to resume diving is a critical safety decision. The consensus suggests a minimum recovery period of approximately 8 weeks, which exceeds the typical 6‐week interval in general ENT practice. This more cautious approach reflects the significant mechanical stress placed on the sinuses during pressure equalization. However, it should be noted that the available literature, including studies by Skevas et al. [13] and Öztürk et al. [8] report no complications at 8 weeks postoperatively, but does not establish that earlier return to diving is unsafe. The proposed 8‐week recovery interval therefore should be interpreted as a pragmatic and precautionary recommendation rather than an evidence‐based absolute threshold. Earlier return to diving may potentially be feasible in selected cases depending on the extent of surgery, mucosal healing, symptom resolution, and anticipated diving exposure. While an 8‐week interval may be appropriate for many recreational divers, its applicability to other groups, such as commercial divers, may be more limited and should be considered in the context of individual risk assessment and occupational demands, and applied with clinical judgment and individualized assessment. The consensus recommends a test dive (e.g., in a pool) as a practical safety measure to confirm adequate pressure equalization without pain or bleeding prior to returning to open‐water environments. This approach is supported by Skevas et al., who observed no recurrent barotrauma during posttreatment pool dives [13], and by Öztürk et al., who reported no complications following a 2‐month recovery period [11]. The principle of a controlled test dive prior return to open‐water diving is also endorsed in the wider otolaryngological literature on diving medicine, in which a supervised test dive in a pool has been proposed as a practical means to verify safe pressure equalization, given that pressure gradients comparable to recreational diving can be reproduced in only 2–3 m of water [5, 7, 8, 17]. However, the suggestion that such a test dive should be supervised under controlled conditions may be overly prescriptive, as the consensus does not define who qualifies as a supervisor, and formal supervision is not clearly supported by available evidence. Accordingly, both the recommended recovery interval and the use of a test dive should be interpreted as pragmatic, precautionary elements within an expert consensus framework, to be applied with clinical judgment and tailored to the individual diver. Limitations and Future Directions These recommendations represent expert opinion (Level 5 evidence), reflecting the limited availability of prospective or randomized studies in diving‐related sinonasal disease. This scarcity has also been highlighted in recent comprehensive reviews of the field, which note a marked paucity of guidelines for otorhinolaryngological fitness to dive in the recreational diver and the consequent need to extrapolate from commercial diving regulations and from rhinosinusitis evidence [7, 17]. The recommendations primarily apply to recreational SCUBA divers and should be interpreted cautiously in other groups, such as commercial divers or aviation personnel. An additional limitation is that the consensus process intentionally adopted a pragmatic conference‐based modified Delphi design rather than a formal guideline development methodology such as RAND/UCLA or Rosenfeld‐style consensus procedures. Quantitative Delphi metrics, anonymized iterative scoring analyses, and full reporting of all statement iterations were not systematically collected. Consequently, the in‐person component may have increased susceptibility to group dynamics and consensus bias. Furthermore, the recommendations do not differentiate extensively between surgical techniques. Most available evidence concerns FESS, whereas balloon sinuplasty was not addressed during the consensus process and falls outside the scope of current recommendations. Despite these limitations, the structured combination of iterative expert feedback, multidisciplinary discussion, and clinical experience enabled the development of pragmatic and clinically applicable recommendations in an area with limited empirical evidence. Future research should prioritize prospective registries of divers undergoing sinus surgery, including different surgical techniques, to better define recovery timelines, recurrence rates, and fitness‐to‐dive outcomes. In addition, more formalized Delphi methodologies incorporating quantitative scoring and comprehensive reporting may further strengthen future consensus efforts. It should be noted that the limited number of references cited in this paper reflects the scarcity of published evidence on sinus pathology in divers. This is precisely the problem this consensus aims to address. We hope the Malta Consensus will serve as a starting point that encourages prospective studies, registries, and ultimately more robust research in this underinvestigated area. Conclusion The “Malta Consensus” represents the first structured initiative to standardize the management of paranasal sinus pathology in SCUBA divers. By prioritizing comprehensive diagnostics, adherence to EPOS guidelines for medical therapy, and postoperative protocols including functional test dives, these recommendations aim to enhance diving safety. Implementation of this framework will foster uniformity in clinical decision‐making and improve collaboration between ENT specialists and diving physicians. Funding The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest.